DSIP (Delta Sleep-Inducing Peptide): The Enigmatic Nonapeptide
A research-focused analysis of Delta Sleep-Inducing Peptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu), its role in sleep regulation, stress response modulation, and its unique position as the only known neuropeptide that crosses the blood-brain barrier efficiently.
Introduction
Delta Sleep-Inducing Peptide (DSIP) is a nine-amino-acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from the cerebral venous blood of rabbits subjected to deep sleep. Despite decades of research, DSIP remains one of the most enigmatic regulatory peptides in neuroscience.
Chemical Profile
- Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
- Molecular Formula: C35H53N11O13
- Molecular Weight: ~847.9 g/mol
- CAS Number: 69431-50-3
- Appearance: White to off-white lyophilized powder
Discovery and Significance
DSIP was discovered in 1970 by Schoenenberger-Monnier and colleagues at the University of Basel. It was identified in the dialysate of cerebral venous blood from rabbits in deep (delta-wave) sleep, making it the first peptide specifically associated with the induction of slow-wave sleep.
Mechanism of Action
Sleep Regulation
DSIP promotes delta-wave (slow-wave) sleep through mechanisms that remain incompletely understood. Unlike many sleep-modulating compounds:
- It does not act on GABA receptors (unlike benzodiazepines)
- It does not directly bind to melatonin receptors
- It does not inhibit histamine release
Current evidence suggests DSIP modulates sleep through:
- Interaction with the suprachiasmatic nucleus (SCN)
- Modulation of serotonin turnover in the raphe nuclei
- Influence on ACTH and cortisol secretion patterns
Blood-Brain Barrier Permeability
DSIP is one of the few neuropeptides that efficiently crosses the blood-brain barrier. This property is attributed to its unique physicochemical properties and possibly active transport mechanisms.
Stress Response Modulation
DSIP influences the hypothalamic-pituitary-adrenal (HPA) axis:
- Normalises elevated corticosteroid levels
- Attenuates stress-induced ACTH release
- Does not suppress basal HPA activity (no iatrogenic adrenal suppression)
Thermoregulation
In preclinical models, DSIP demonstrates hypothermic effects, reducing core body temperature. This property may be linked to its sleep-promoting activity.
Preclinical Research
Sleep Architecture
In EEG-monitored studies, DSIP administration is associated with:
- Increased total sleep time
- Enhanced delta-wave (N3) sleep duration
- Reduction in sleep onset latency
- No disruption of REM sleep architecture
Stress and Adaptation
DSIP has been studied in models of chronic stress:
- Reduces stress-induced hyperthermia
- Normalises disrupted sleep patterns in stressed subjects
- Does not produce the cognitive impairment associated with classical anxiolytics
Endocrine Effects
- Modulates growth hormone pulsatility
- Influences luteinising hormone secretion patterns
- May normalise disrupted cortisol circadian rhythms
Analytical Specifications
| Parameter | Specification |
|---|---|
| Purity | >= 98% (HPLC) |
| Identity | Confirmed by mass spectrometry |
| Peptide content | >= 80% (NPN) |
| Bacterial endotoxins | < 10 EU/mg |
Frequently Asked Questions
What is the CAS number for DSIP?
The CAS number for DSIP is 69431-50-3.
Does DSIP cross the blood-brain barrier?
Yes, DSIP is one of the few neuropeptides that crosses the blood-brain barrier efficiently, which is one of its most remarkable properties.
What is the molecular weight of DSIP?
DSIP has a molecular weight of approximately 847.9 g/mol.
Storage and Handling
- Store at -20C as lyophilized powder
- Protect from light and moisture
- Reconstitute with bacteriostatic water
- Use within 30 days of reconstitution
Conclusion
DSIP remains a scientifically fascinating peptide with unique properties in sleep regulation, stress response modulation, and neuroendocrine signalling. Its blood-brain barrier permeability and physiological mechanism of action distinguish it from conventional sleep-modulating agents.
All products sold by Kingston Peptides are intended exclusively for in vitro research and analytical purposes.